The majority of new prescriptions filled for Wegovy pill (more than 80%) are for people new to GLP-1 therapy, indicating the oral formulation is expanding the obesity treatment market, rather than replacing existing therapies. "Wegovy offers adults with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events such as death, heart attack, or stroke in adults with obesity with known heart disease making Wegovy pill truly distinct
GLP-1s help bring those signals back into balance so weight loss feels more manageable instead of like a constant battle
Until those data arrive, claims about meaningful, reproducible benefits should be treated as hypotheses
With time, you can gradually increase it
I cant say enough great things about this company and ease of use, from start to finish
The result is often skin that appears looser around the jawline, cheeks, neck, and other areas of the face and body